Cancer Research UK wins website award
THURSDAY 18 DECEMBER 2008
Cancer Research UK has received an award for its website at the annual Website of the Year awards.
The charity came away with both of the available prizes in the category for Non Profit websites.
It achieved the title 'Best Non Profit Website', which is awarded to the website with the highest average scores for content, navigation and design, as well as the 'Most Popular Non Profit Website' for achieving the highest number of public votes.
Winning this award is a wonderful early Christmas present for the charity, and a testament to the hard work and dedication of our staff.
- Roseann Wilson, director of internet and new media, Cancer Research UK
Roseann Wilson, Cancer Research UK's director of Internet & New Media, said:"The internet has had a huge impact on how charities engage, fundraise and communicate. It is an important medium in helping us achieve our goals, for example in helping people understand cancer and the progress we are making or enabling us to raise sufficient funds to ensure future progress.
"This means using digital media efficiently and effectively alongside traditional media. Winning this award is a wonderful early Christmas present for the charity, and a testament to the hard work and dedication of our staff."
A total of 223 websites were nominated across 18 categories and more than 1.5 million votes were cast between November 3rd and December 8th.
Other winners included well-known brands such as Nokia, YouTube and BBC News, highlighting the strength of the competition.
Please help us improve our news stories by taking our short survey
Number of Britons diagnosed with alcohol-related cancers exceeds Wimbledon's Centre Court
Benefits of international tobacco smuggling protocol would outweigh costs
Women and GPs lack awareness of ovarian cancer symptoms
One in 25 deaths attributable to alcohol
Patients with suspected cancer to see specialist within two weeks
Animal fats linked to pancreatic cancer
Promising experimental drug targets cancer 'Achilles heel'
Cervical cancer screening age to stay at 25
NICE approves lenalidomide for multiple myeloma patients who have received previous treatments
Scientists identify inhibitor of tumour spread
